We are live on ! Find out more
LP

LMR Partners Portfolio holdings

AUM $45.4B
1-Year Est. Return 60.68%
This Fund
S&P 500
This Quarter Est. Return
+20.79%
1 Year Est. Return
+60.68%
3 Year Est. Return
+183.94%
5 Year Est. Return
+215.13%
10 Year Est. Return
+663.15%
AUM
$22.7B
AUM Growth
+$8.71B
Cap. Flow
+$5.15B
Cap. Flow %
22.72%
Top 10 Hldgs %
37.26%
Holding
1,723
New
374
Increased
276
Reduced
287
Closed
300

Top Buys

Rank Stock Value
1
K
Kellanova
K
+$138M
2
AZN icon
AstraZeneca
AZN
+$99.4M
3
IVV icon
iShares Core S&P 500 ETF
IVV
+$96.6M
4
MSTR icon
Strategy Inc
MSTR
+$89.6M
5
CYBR
CyberArk
CYBR
+$78.7M

Sector Composition

Rank Sector Weight
1 Technology 7.18%
2 Financials 3.09%
3 Communication Services 2%
4 Healthcare 1.51%
5 Consumer Discretionary 1.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GSK icon
176
GSK
GSK
$103B
$16.6M 0.07%
384,302
K
177
CALL
DELISTED
Kellanova
K
$16.4M 0.07%
+200,000
New +$15.9M
SAND
178
DELISTED
Sandstorm Gold
SAND
$16.3M 0.07%
+1,305,604
New +$13.9M
BSX icon
179
PUT
Boston Scientific
BSX
$65.8B
$16.3M 0.07%
167,100
+162,900
+3,879% +$16.9M
POLE
180
Andretti Acquisition Corp II
POLE
$319M
$16.2M 0.07%
1,550,000
-150,000
-9% -$1.56M
BULLW
181
Webull Corp Warrants
BULLW
$89.7M
$16.2M 0.07%
2,664,529
+69,020
+3% +$389K
HIMS icon
182
Hims & Hers Health
HIMS
$6.5B
$16.1M 0.07%
284,706
+119,851
+73% +$6.14M
SLV icon
183
iShares Silver Trust
SLV
$28.1B
$16.1M 0.07%
379,192
+179,192
+90% +$6.43M
INFA
184
DELISTED
Informatica
INFA
$16M 0.07%
+643,843
New +$15.9M
GDX icon
185
VanEck Gold Miners ETF
GDX
$23B
$15.9M 0.07%
208,000
-266,812
-56% -$16.1M
AMPX.WS icon
186
Amprius Technologies Warrants
AMPX.WS
$360M
$15.8M 0.07%
4,312,373
+1,366,478
+46% +$2.92M
FIG
187
Figma
FIG
$11.2B
$15.7M 0.07%
+303,348
New +$20.8M
MACI
188
Melar Acquisition Corp I
MACI
$15.6M 0.07%
1,485,000
CVX icon
189
CALL
Chevron
CVX
$388B
$15.6M 0.07%
100,200
+98,700
+6,580% +$15.3M
CIEN icon
190
Ciena
CIEN
$55.3B
$15.5M 0.07%
106,500
-178,500
-63% -$18.2M
PDD icon
191
Pinduoduo
PDD
$118B
$15.5M 0.07%
117,082
+74,609
+176% +$8.83M
SNY icon
192
PUT
Sanofi
SNY
$104B
$15.3M 0.07%
+325,000
New +$15.7M
VRNA
193
DELISTED
Verona Pharma
VRNA
$15.3M 0.07%
+143,200
New +$15M
GDX icon
194
PUT
VanEck Gold Miners ETF
GDX
$23B
$15.3M 0.07%
200,000
-50,000
-20% -$3.01M
MDB icon
195
CALL
MongoDB
MDB
$24B
$15.3M 0.07%
49,200
+5,000
+11% +$1.29M
MRNA icon
196
PUT
Moderna
MRNA
$21.5B
$15.3M 0.07%
590,600
+539,200
+1,049% +$15M
UDR icon
197
UDR
UDR
$12.9B
$15.2M 0.07%
+408,463
New +$15.9M
IBN icon
198
ICICI Bank
IBN
$106B
$15.2M 0.07%
501,734
-345,140
-41% -$11.3M
CVLT icon
199
Commault Systems
CVLT
$5.89B
$15.1M 0.07%
80,000
+60,000
+300% +$10.8M
TLNCU
200
Talon Capital Corp Units
TLNCU
$15.1M 0.07%
+1,500,000
New +$15M

Similar funds

LMR Partners's Q3 2025 Portfolio in Review

As of Q3 2025, LMR Partners held 1,723 positions worth $22.7B, up 62% from $14B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

LMR Partners deployed $5.15B of net new capital in Q3 2025, opening 374 new positions and adding to 276 existing holdings. Its largest new stake was iShares Core S&P 500 ETF: 150,000 shares worth $100M.

By sector, the portfolio is most concentrated in Technology at 7.2% of assets, down from 10% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was iShares National Muni Bond ETF, an estimated $154M trimmed.

  • LMR Partners's largest Q3 2025 buy was iShares Core S&P 500 ETF: 150,000 shares worth $100M.
  • LMR Partners added most to Kellanova in Q3 2025, an estimated $138M increase.
  • LMR Partners's biggest Q3 2025 reduction was iShares National Muni Bond ETF, cutting an estimated $154M.
  • LMR Partners fully exited Amazon in Q3 2025, selling an estimated $67.6M.
  • LMR Partners's ten largest holdings make up 37% of its $22.7B portfolio in Q3 2025.
  • LMR Partners opened 374 new positions and closed 300 in Q3 2025.
  • LMR Partners's portfolio value rose 62% quarter-over-quarter to $22.7B.

Based on LMR Partners's 13F filing for Q3 2025, filed 14 Nov 2025.